Leuthold Group, LLC Gilead Sciences, Inc. Transaction History

Leuthold Group, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $2.62 Million - $2.98 Million	-43,597 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $2.53 Million - $2.88 Million	-44,613 Reduced 50.58%	43,597 $2.54 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $108,364 - $136,249	-1,745 Reduced 1.94%	88,210 $5.57 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $163,560 - $189,924	-2,261 Reduced 2.45%	89,955 $6.92 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $476,739 - $610,634	-7,612 Reduced 7.63%	92,216 $6.89 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $234,340 - $257,767	-3,803 Reduced 3.67%	99,828 $6.49 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $2.23 Million - $2.46 Million	35,703 Added 52.56%	103,631 $6.57 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $268,453 - $301,039	-4,339 Reduced 6.0%	67,928 $4.59 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.79 Million - $2.01 Million	28,658 Added 65.72%	72,267 $4.7 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $183,557 - $239,528	-3,032 Reduced 6.5%	43,609 $2.73 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $3.32 Million - $3.68 Million	46,641 New	46,641 $3.6 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $6.95 Million - $8.47 Million	-95,395 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.67 Million - $1.96 Million	23,508 Added 32.7%	95,395 $6.83 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $7,427 - $8,803	-103 Reduced 0.14%	71,887 $5.82 Million
Q2 2017 Aug 14, 2017	BUY	N/A	71,990	71,990 $5.1 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.